Urinary detection of conjugated and unconjugated anabolic steroids by dilute-and-shoot liquid chromatography-high resolution mass spectrometry

Drug Testing and Analysis

Volumn 7, Issue 2, 2015, Pages 95-108

  Tudela, Eva ^a   Deventer, Koen ^a   Geldof, Lore ^a   Van Eenoo, Peter ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Anabolic steroids; Doping; Glucuronide conjugates; In vitro synthesis; LC MS; Urine

Indexed keywords

BIOMOLECULES; GAS CHROMATOGRAPHY; LIPIDS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SULFUR COMPOUNDS;

ANABOLIC STEROID; DETECTION LIMITS; GLUCURONIDE CONJUGATES; GLUCURONIDES; IN VITRO SYNTHESIS; IN-VITRO; LIQUID CHROMATOGRAPHY - MASS SPECTROMETRIES; LIQUID CHROMATOGRAPHY-HIGH RESOLUTION MASS SPECTROMETRIES; URINE; VITRO SYNTHESIS;

METABOLITES;

ANABOLIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BOLASTERONE; BOLDENONE; CALUSTERONE; CLOSTEBOL; CORTICOSTEROID; DANAZOL; DROSTANOLONE; DRUG METABOLITE; FLUOXYMESTERONE; FORMEBOLONE; GESTRINONE; GLUCURONIDE; MESTEROLONE; METANDIENONE; METENOLONE; METHANDRIOL; METHYLTESTOSTERONE; NANDROLONE; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXANDROLONE; OXYMETHOLONE; STANOZOLOL; SULFATE; TETRAHYDROGESTRINONE; TRENBOLONE;

ARTICLE; CONTROLLED STUDY; DERIVATIZATION; DILUTION; DRUG CONJUGATION; DRUG EXCRETION; DRUG URINE LEVEL; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROLYSIS; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; LIVER MICROSOME; MASS SPECTROMETRY; PRIORITY JOURNAL; URINALYSIS;

EID: 84964311559     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1650     Document Type: Article

References (45)

1. C. Maravelias, A. Dona, M. Stefanidou, C. Spiliopoulou. Adverse effects of anabolic steroids in athletes - A constant threat. Toxicol. Lett. 2005, 158, 167.
2. World Anti-Doping Agency (WADA). The 2013 Prohibited List, International Standard. Available at: http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2013/WADA-Prohibited-List-2013-EN.pdf [7 February 2013].
3. World Anti-Doping Agency (WADA). 2011 Adverse Analytical Findings and Atypical Findings Reported by Accredited Laboratories, 2011. http://www.wada-ama.org/Documents/Resources/Testing-Figures/WADA-2011-Laboratory-Testing-Figures.pdf [6 January 2013].
4. W. Schanzer. Metabolism of anabolic androgenic steroids. Clin. Chem. 1996, 42, 1001.
5. B.W. Jeon, H.H. Yoo, E.S. Jeong, H.J. Kim, C. Jin, D.H. Kim, J. Lee. LC-ESI/MS/MS method for rapid screening and confirmation of 44 exogenous anabolic steroids in human urine. Anal. Bioanal. Chem. 2011, 401, 1353.
6. M. Mazzarino, M. Orengia, F. Botre. Application of fast gas chromatography/mass spectrometry for the rapid screening of synthetic anabolic steroids and other drugs in anti-doping analysis. Rapid Commun. Mass Spectrom. 2007, 21, 4117.
7. P. Van Eenoo, W. Van Gansbeke, N. De Brabanter, K. Deventer, F.T. Delbeke. A fast, comprehensive screening method for doping agents in urine by gas chromatography-triple quadrupole mass spectrometry. J. Chromatogr. A 2011, 1218, 3306.
8. L.D. Bowers, Sanaullah. Direct measurement of steroid sulfate and glucuronide conjugates with high-performance liquid chromatography mass spectrometry. J. Chromatogr. B 1996, 687, 61.
9. U. Mareck, H. Geyer, G. Opfermann, M. Thevis, W. Schanzer. Factors influencing the steroid profile in doping control analysis. J. Mass Spectrom. 2008, 43, 877.
10. O.J. Pozo, K. Deventer, P. Van Eenoo, F.T. Delbeke. Efficient approach for the comprehensive detection of unknown anabolic steroids and metabolites in human urine by liquid chromatography - Electrospray-tandem mass spectrometry. Anal. Chem. 2008, 80, 1709.
11. E. Houghton, L. Grainger, M.C. Dumasia, P. Teale. Application of gas-chromatography mass-spectrometry to steroid analysis in equine sports - Problems with enzyme hydrolysis. Org. Mass Spectrom. 1992, 27, 1061.
12. B. Hauser, D. Schulz, C. Boesch, T. Deschner. Measuring urinary testosterone levels of the great apes - Problems with enzymatic hydrolysis using Helix pomatia juice. Gen. Comp. Endocrinol. 2008, 158, 77.
13. E. Tudela, K. Deventer, P. Van Eenoo. Sensitive detection of 3'-hydroxy-stanozolol glucuronide by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2013, 1292, 195.
14. W. Schaenzer, S. Guddat, A. Thomas, G. Opfermann, H. Geyer, M. Thevis. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing. Drug Test. Anal. 2013, 5, 810.
15. O.J. Pozo, P. Van Eenoo, K. Deventer, F.T. Delbeke. Ionization of anabolic steroids by adduct formation in liquid chromatography electrospray mass spectrometry. J. Mass Spectrom. 2007, 42, 497.
16. L. Hintikka, T. Kuuranne, A. Leinonen, M. Thevis, W. Schaenzer, J. Halket, D. Cowan, J. Grosse, P. Hemmersbach, M.W.F. Nielen, R. Kostiainen. Liquid chromatographic-mass spectrometric analysis of glucuronide-conjugated anabolic steroid metabolites: Method validation and interlaboratory comparison. J. Mass Spectrom. 2008, 43, 965.
17. O.J. Pozo, P. Van Eenoo, W. Van Thuyne, K. Deventer, F.T. Delbeke. Direct quantification of steroid glucuronides in human urine by liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. A 2008, 1183, 108.
18. T. Kuuranne, T. Kotiaho, S. Pedersen-Bjergaard, K.E. Rasmussen, A. Leinonen, S. Westwood, R. Kostiainen. Feasibility of a liquid-phase microextraction sample clean-up and liquid chromatographic/mass spectrometric screening method for selected anabolic steroid glucuronides in biological samples. J. Mass Spectrom. 2003, 38, 16.
19. A. Fabregat, O.J. Pozo, J. Marcos, J. Segura, R. Ventura. Use of LC-MS/MS for the open detection of steroid metabolites conjugated with glucuronic acid. Anal. Chem. 2013, 85, 5005.
20. M.H. Choi, K.R. Kim, B.C. Chung. Simultaneous determination of urinary androgen glucuronides by high temperature gas chromatography-mass spectrometry with selected ion monitoring. Steroids 2000, 65, 54.
21. J.P. Antignac, A. Brosseaud, I. Gaudin-Hirret, F. Andre, B. Le Bizec. Analytical strategies for the direct mass spectrometric analysis of steroid and corticosteroid phase II metabolites. Steroids 2005, 70, 205.
22. F. Badoud, E. Grata, J. Boccard, D. Guillarme, J.-L. Veuthey, S. Rudaz, M. Saugy. Quantification of glucuronidated and sulfated steroids in human urine by ultra-high pressure liquid chromatography quadrupole time-of-flight mass spectrometry. Anal. Bioanal. Chem. 2011, 400, 503.
23. K.A. Bean, J.D. Henion. Direct determination of anabolic steroid conjugates in human urine by combined high-performance liquid chromatography and tandem mass spectrometry. J. Chromatogr. B 1997, 690, 65.
24. J.J. Schulze, J.O. Thorngren, M. Garle, L. Ekstrom, A. Rane. Androgen sulfation in healthy UDP-Glucuronosyl transferase 2B17 enzyme-deficient men. J. Clin. Endocrinol. Metab. 2011, 96, 3440.
25. K. Deventer, O.J. Pozo, A.G. Verstraetec, P.V. Eenoo. Dilute-and-shoot-liquid chromatography-mass spectrometry for urine analysis in doping control and analytical toxicology. TrAC 2014, 55, 1.
26. World Anti-Doping Agency (WADA). Technical Document - TD2013MRPL (2013), Minimum Required Performance Levels for Detection of Prohibited Substances, Available at: http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-IS-Laboratories/Technical_Documents/WADA-TD2013MRPL-Minimum-Required-Performance-Levels-v1-2012-EN.pdf [7 February 2013].
27. World Anti-Doping Agency (WADA). International Standard for Laboratories, version 7.0., 2012. Available at: http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-IS-Laboratories/ISL/WADA_Int_Standard_Laboratories_2012_EN.pdf [13 January 2012].
28. Eurachem. The fitness for purpose of analytical methods. A laboratory guide to method validation and related topics. Eurachem, Teddington, UK, 1998.
29. World Anti-Doping Agency (WADA). Technical Document - TD2010IDCR, Identification criteria for qualitative assays incorporating column chromatography and mass spectrometry. Available at: http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-IS-Laboratories/WADA_TD2010IDCRv1.0_Identification%20Criteria%20for%20Qualitative%20Assays_May%2008%202010_EN.doc.pdf [13 August 2011].
30. B.K. Matuszewski, M.L. Constanzer, C.M. Chavez-Eng. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75, 3019.
31. W. Schanzer, M. Donike. Metabolism of anabolic-steroids in man - Synthesis and use of reference substances for identification of anabolic-steroid metabolites. Anal. Chim. Acta 1993, 275, 23.
32. K. Deventer, O.J. Pozo, P. Van Eenoo, F.T. Delbeke. Qualitative detection of diuretics and acidic metabolites of other doping agents in human urine by high-performance liquid chromatography-tandem mass spectrometry comparison between liquid-liquid extraction and direct injection. J. Chromatogr. A 2009, 1216, 5819.
33. K. Deventer, O.J. Pozo, P. Van Eenoo, F.T. Delbeke. Development and validation of an LC-MS/MS method for the quantification of ephedrines in urine. J. Chromatogr. B 2009, 877, 369.
34. C.W. Weykamp, T.J. Penders, N.A. Schmidt, A.J. Borburgh, J.F. Vandecalseyde, B.J. Wolthers. Steroid profile for urine - Reference values. Clin. Chem. 1989, 35, 2281.
35. L.L. Engel, J. Alexander, M. Wheeler. Urinary metabolites of administered 19-Nortestosterone. J. Biol. Chem. 1958, 231, 159.
36. B. Le Bizec, F. Monteau, I. Gaudin, F. Andre. Evidence for the presence of endogenous 19-norandrosterone in human urine. J. Chromatogr. B 1999, 723, 157.
37. P. Van Eenoo, F.T. Delbeke, F.H. de Jong, P. De Backer. Endogenous origin of norandrosterone in female urine: Indirect evidence for the production of 19-norsteroids as by-products in the conversion from androgen to estrogen. J. Steroid Biochem. Mol. Biol. 2001, 78, 351.
38. O.J. Pozo, W. Van Thuyne, K. Deventer, P. Van Eenoo, F.T. Delbeke. Elucidation of urinary metabolites of fluoxymesterone by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry. J. Mass Spectrom. 2008, 43, 394.
39. R. Masse, H. Bi, P.D. Studies on anabolic steroids. VII. Analysis of urinary metabolites of formebolone in man by gas chromatography-mass spectrometry. Anal. Chim. Acta 1991, 247, 211.
40. B.S. Macdonald, P.J. Sykes, P.M. Adhikary, R.A. Harkness. Identification of 17α-hydroxy-17β-methylandrosta-1, 4-dien-3-one as a metabolite of 17β-hydroxy-17α-methylandrosta-1, 4-dien-3-one in man. Biochem. J. 1971, 122, 26P.
41. A.G. Fragkaki, Y.S. Angelis, A. Tsantili-Kakoulidou, M. Koupparis, C. Georgakopoulos. Schemes of metabolic patterns of anabolic androgenic steroids for the estimation of metabolites of designer steroids in human urine. J. Steroid Biochem. Mol. Biol. 2009, 115, 44.
42. T. Kuuranne, K.H. Pystynen, M. Thevis, A. Leinonen, W. Schanzer, R. Kostiainen. Screening of in vitro synthesised metabolites of 4, 9, 11-trien-3-one steroids by liquid chromatography-mass spectrometry. Eur. J. Mass Spectrom. 2008, 14, 181.
43. K. Schubert, K. Wehrberg. Metabolism of steroid drugs. II. Isolation and characterization of metabolites of 4-chloro-17alpha-methy-17beta-hydroxy-1, 4-androstadien-3-one. Endokrinologie 1970, 55, 257.
44. H.W. Duerbeck, I. Bueker, B. Scheulen, B. Telin. GC and capillary column GC/MS determination of synthetic anabolic steroids. II. 4-Chloro-methandienone (oral turinabol) and its metabolites. J. Chromatogr. Sci. 1983, 21, 405.
45. T. Sobolevsky, G. Rodchenkov. Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine. J. Steroid Biochem. Mol. Biol. 2012, 128, 121.